Background Image of Global Banner Close Global Banner
Apply Now

Seeking Applications for a
New CZ Biohub

We’re accepting joint applications from universities and other research institutions to create the next Biohub in the network.

Apply Now

BACK TO ALL

MATTHEW PORTEUS, M.D., PH.D.

Porteus uses genome editing as curative therapy for genetic diseases, as exemplified by his correction of the mutation in sickle cell disease in hematopoietic stem and progenitor cells. He is now combining genome editing with synthetic biology to engineer cells having new phenotypic properties, such as engineering resistance to HIV and enhancing wound healing.

Photo of MATTHEW PORTEUS, M.D., PH.D.